About Biobank
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA. The human biobanks work by systematic collection of biological samples from patients and other members of the public. Biobanks significantly vary in size such as biobanks held in medical institutions hold relatively modest number of samples compared with a national biobank, which hold a large number of samples. Biobanks are commonly used to support research of most common types of genetic disorders, for developing personalized medicine, for stem cell research, and for maintaining and updating age demographic databases.
TechNavio's analysts forecast the Global Biobanking market to grow at a CAGR of 7.07 percent over the period 2014-2019.
Covered in this Report
The Global Biobanking market can be divided into two segments: Equipment and Consumables. This report covers the present scenario and the growth prospects of the Global Biobanking market for the period 2015-2019.
TechNavio's report, Global Biobanking Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Beckman Coulter
• Tecan
• Thermo Fischer Scientific
Other Prominent Vendors
• Askion GmBH
• B&C Group
• BioBank
• BioCryo
• BioRep SRL
• BioStorage Technologies
• Bluechip
• Brooks Life Science Systems
• Cryo Bio System
• CryoXtract
• DNA Genotek
• Excilone
• Fluidx
• Indivumed
• LVL Technologies
• Micronic
• Promega
• QIAGEN
• RURO
• Seralab
• SOL Group
• Tissue Solutions
• Trans-Hit Biomarkers
• Wildcat Laboratory Solutions
Market Driver
• Advances in Technology
• For a full, detailed list, view our report
Market Challenge
• Public Trust for Biobanking
• For a full, detailed list, view our report
Market Trend
• Increase in Strategic Collaborations
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview
06.1 Biobanks
06.2 Types of Biobank
06.3 Classification of Biobanks
06.3.1 Population-based Biobanks
06.3.2 Disease-based Biobanks
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
7.3 Five Forces Analysis
08. Biobank Funding and Financial Sustainability
09. Cost of Biobanks
09.1 Cost Components
09.1.1 Capital Equipment
09.1.2 Personnel Costs
09.1.3 Consumables
09.2 Cost Analysis
10. Harmonization of Biobanking
11. Geographical Segmentation
11.1 Biobanking Market in EMEA Region
11.1.1 Market Size and Forecast
11.2 Biobanking Market in Americas
11.2.1 Market Size and Forecast
11.3 Biobanking Market in APAC Region
11.3.1 Market Size and Forecast
12. Key Focus Countries
12.1 China
12.2 Japan
12.3 Singapore
12.4 Sweden
12.5 UK
12.6 US
13. Key Takeaways Global Biobanking Market 2015-2019
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2013
21.3 Other Prominent Vendors
22. Key Vendor Analysis
22.1 Beckman Coulter
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Business Segmentation 2013
22.1.4 Geographical Segmentation by Revenue 2013
22.1.5 Business Strategy
22.1.6 Recent Developments
22.1.7 SWOT Analysis
22.2 Tecan Group
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Strategy
22.2.5 Revenue Segmentation by Business
22.2.6 Sales by Geographical Segmentation
22.2.7 Key Information
22.2.8 SWOT Analysis
22.3 Thermo Fisher Scientific
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation
22.3.4 Business Segmentation by Revenue
22.3.5 Product Segmentation by Revenue
22.3.6 Geographical Segmentation by Revenue 2013
22.3.7 Business Strategy
22.3.8 Key Information
22.3.9 SWOT Analysis
23. Other Reports in this Series
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Working of a Typical Biobank
Exhibit 3: Global Biobanking Market 2014-2019 (US$ million)
Exhibit 4: Actors in the Complex Biobank Governance Structure
Exhibit 5: Revenue Models of Biobanks
Exhibit 6: Common Cryopreservation Systems Used in Biobanks
Exhibit 7: List of Consumables Used in Biobanks
Exhibit 8: Cost of Equipment Used in Biobanks
Exhibit 9: Cost of Consumables Used in Biobanks
Exhibit 10: Estimated Total Cost of Equipment and Consumables Required for a Biobank During First Year of Establishment
Exhibit 11: Trend of Estimated Investment Required by a Biobank in Capital Equipment and Consumables Over a Period
Exhibit 12: Organizations and Initiatives Toward Biobank Harmonization
Exhibit 13: Key Factors Involved in Harmonization of Biobanks
Exhibit 14: Key Focus Areas in Harmonization of Biobanks
Exhibit 15: Organizations and Initiatives in Harmonizing Science and Infrastructure
Exhibit 16: Initiatives on Biobanking Resource Tools and Databases
Exhibit 17: Segmentation of Global Biobanking Market by Geography 2014
Exhibit 18: Segmentation of Global Biobanking Market by Geography 2019
Exhibit 19: Segmentation of Global Biobanking Market by Geography 2014-2019 (US$ million)
Exhibit 20: Biobanking Market in EMEA Region 2014-2019 (US$ million)
Exhibit 21: Biobanking Market in Americas 2014-2019 (US$ million)
Exhibit 22: Biobanking Market in APAC Region 2014-2019 (US$ million)
Exhibit 23: Geographical Snapshot
Exhibit 24: Timeline of Biobank Initiatives in China
Exhibit 25: Beckman Coulter: Business Segmentation 2013
Exhibit 26: Beckman Coulter: Geographical Segmentation by Revenue 2013
Exhibit 27: Business Segmentation of Tecan Group Ltd. 2013
Exhibit 28: Revenue Segmentation of Tecan Group Ltd. for 2011-2013 (US$ million)
Exhibit 29: Sales by Geographical Segmentation of Tecan Group Ltd. (2013)
Exhibit 30: Thermo Fisher: Business Segmentation
Exhibit 31: Thermo Fisher: Business Segmentation by Revenue 2013
Exhibit 32: Thermo Fisher: Product Segmentation by Revenue 2013
Exhibit 33: Thermo Fisher: Geographical Segmentation by Revenue 2013
